Cover Image
Market Research Report

Cytomegalovirus (CMV) Infection- Epidemiology Forecast to 2028

Published by DelveInsight Business Research LLP Product code 402149
Published Content info 50 Pages
Delivery time: 1-2 business days
Price
Back to Top
Cytomegalovirus (CMV) Infection- Epidemiology Forecast to 2028
Published: January 1, 2019 Content info: 50 Pages
Description

DelveInsight's "Cytomegalovirus (CMV) Infection - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Cytomegalovirus (CMV) Infection epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

  • United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan

Study Period: 2016-2028

Cytomegalovirus (CMV) Infection Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Cytomegalovirus (CMV) Infection in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Cytomegalovirus (CMV) Infection outlook. It also includes the explanation of changing trends of epidemiology outlining the Cytomegalovirus (CMV) Infection scenario.

Cytomegalovirus (CMV) Infection Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Cytomegalovirus (CMV) Infection thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

  • The report covers detailed overview of Cytomegalovirus (CMV) Infection explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan
  • The Cytomegalovirus (CMV) Infection Report assesses the disease risk and burden and highlights the unmet needs
  • It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

  • 10 Year Forecast
  • 7MM Coverage
  • Total Cases in Cytomegalovirus (CMV) Infection

Key assessments

  • Patient Segmentation in Cytomegalovirus (CMV) Infection
  • Cytomegalovirus (CMV) Infection Risk & Burden
  • Factors driving growth in a specific Cytomegalovirus (CMV) Infection patient population
Table of Contents
Product Code: DIEI0007

Table of Contents

1. Report Introduction

2. Cytomegalovirus (CMV) Infection Epidemiology Overview at a Glance

  • 2.1. Patient Share Distribution of Cytomegalovirus (CMV) Infection in 2016
  • 2.2. Patient Share Distribution of Cytomegalovirus (CMV) Infection in 2028

3. Disease Background and Overview: Cytomegalovirus (CMV) Infection

  • 3.1. Introduction
  • 3.2. Symptoms
  • 3.3. Etiology
  • 3.4. Risk Factors
  • 3.5. Pathophysiology
  • 3.6. Diagnosis
  • 3.7. Treatment

4. Epidemiology and Patient Population

  • 4.1. Key Findings
  • 4.2. Total Prevalent/ Incident Patient Population of Cytomegalovirus (CMV) Infection in 7MM
  • 4.3. Total Prevalent/ Incident Patient Population of Cytomegalovirus (CMV) Infection in 7MM - By Countries

5. Epidemiology of Cytomegalovirus (CMV) Infection by Countries

  • 5.1. United States
    • 5.1.1. Assumptions and Rationale
    • 5.1.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.1.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection *
    • 5.1.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.1.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.2. EU5
  • 5.3. Assumptions and Rationale
  • 5.4. Germany
    • 5.4.1. Assumptions and Rationale
    • 5.4.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.4.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.4.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.4.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.5. France
    • 5.5.1. Assumptions and Rationale
    • 5.5.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.5.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.5.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.5.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.6. Italy
    • 5.6.1. Assumptions and Rationale
    • 5.6.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.6.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.6.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.6.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.7. Spain
    • 5.7.1. Assumptions and Rationale
    • 5.7.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.7.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.7.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.7.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.8. United Kingdom
    • 5.8.1. Assumptions and Rationale
    • 5.8.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.8.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.8.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.8.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection
  • 5.9. Japan
    • 5.9.1. Assumptions and Rationale
    • 5.9.2. Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection
    • 5.9.3. Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection*
    • 5.9.4. Sex- Specific Cases of the Cytomegalovirus (CMV) Infection*
    • 5.9.5. Diagnosed Cases of the Cytomegalovirus (CMV) Infection

6. Unmet Needs of the Cytomegalovirus (CMV) Infection

7. Appendix

8. Report Methodology

  • 8.1. Sources

9. DelveInsight Capabilities

10. Disclaimer

11. About DelveInsight

Indication Specific

List of Tables

  • Table 1: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM
  • Table 2: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM by Countries
  • Table 3: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Table 4: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Table 5: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Table 6: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Table 7: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Table 8: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Table 9: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Table 10: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Table 11: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Table 12: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Table 13: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Table 14: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Table 15: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Table 16: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Table 17: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Table 18: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Table 19: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Table 20: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Table 21: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Table 22: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Table 23: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Table 24: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Table 25: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Table 26: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Table 27: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
  • Table 28: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Table 29: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Table 30: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)

List of Figures

  • Figure 1: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM
  • Figure 2: Total Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in 7MM by Countries
  • Figure 3: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Figure 4: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Figure 5: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)*
  • Figure 6: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in United States (2016-2028)
  • Figure 7: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Figure 8: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Figure 9: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028) *
  • Figure 10: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Germany (2016-2028)
  • Figure 11: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Figure 12: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Figure 13: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028) *
  • Figure 14: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in France (2016-2028)
  • Figure 15: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Figure 16: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Figure 17: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028) *
  • Figure 18: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Italy (2016-2028)
  • Figure 19: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Figure 20: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Figure 21: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028) *
  • Figure 22: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Spain (2016-2028)
  • Figure 23: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Figure 24: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Figure 25: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028) *
  • Figure 26: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in UK (2016-2028)
  • Figure 27: Prevalent/Incident Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
  • Figure 28: Sub-Type Specific cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Figure 29: Sex- Specific Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028) *
  • Figure 30: Diagnosed Cases of the Cytomegalovirus (CMV) Infection in Japan (2016-2028)
Back to Top